Evidence map›Paper›PMID 35310069›Full record

ArticleSTAR protocols2022

Medium throughput protocol for genome-based quantification of intracellular mycobacterial loads and macrophage survival during

Shivraj M Yabaji, Sujoy Chatterjee, Emily Waligursky, Alexander Gimelbrant, Igor Kramnik

Abstract read
In one paragraph

Article in STAR protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Lung epithelial injury impairs early host immune responses to Mycobacterium tuberculosis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shivraj M YabajiNational Emerging Infectious Diseases Laboratories (NEIDL), Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.
Sujoy ChatterjeeNational Emerging Infectious Diseases Laboratories (NEIDL), Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.
Emily WaligurskyNational Emerging Infectious Diseases Laboratories (NEIDL), Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.
Alexander GimelbrantDepartment of Cancer Biology and Center for Cancer Systems Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Igor KramnikNational Emerging Infectious Diseases Laboratories (NEIDL), Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston University, Boston, MA 02118, USA.

Funding

Necrosis in pulmonary TB granulomas: dynamics, mechanisms, therapiesR01HL126066 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KRAMNIK, IGOR, NIEDERWEIS, MICHAEL · 2016 to 2025
$5.6M
Aberrant immune activation in the tuberculosis granuloma: a pivotal role in necrosisR01HL133190 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BISHAI, WILLIAM RAMSES, KRAMNIK, IGOR · 2016 to 2019
$3.0M
Toxin secretion and trafficking by Mycobacterium tuberculosisR01AI175106 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MICHAEL NIEDERWEIS · 2023 to 2026
$3.0M
NHLBI NIH HHS R01 HL126066NHLBI NIH HHS R01 HL133190NIAID NIH HHS R01 AI175106
6 · The paper itself

Abstract

Here, we present a streamlined protocol for assessing intracellular Mycobacterium tuberculosis (Mtb) loads in macrophages. This protocol describes the simultaneous assessment of macrophage viability using automated microscopy. Further, we detail the quantification of mycobacterial loads using a rapid, inexpensive, and accurate approach for mycobacterial DNA isolation from paraformaldehyde-fixed macrophages. Simultaneous assessment of the bacterial loads using internal standard and macrophage viability allows for precise quantification of the effects of perturbations on Mtb and host cells while accounting for technical artifacts. For complete details on the use and execution of this protocol, please refer to Chatterjee et al. (2021).

Indexed as

Mycobacterium tuberculosisMacrophagesCell-based AssaysImmunologyMicrobiologyMicroscopyMolecular Biology

Identifiers

PMID35310069
PMCPMC8931439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.